| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.093 | 0.09 |